Ernexa Therapeutics Inc. (ERNAW) Gross margin 2024–2025
Ernexa Therapeutics Inc. (ERNAW) gross margin by fiscal year — reported gross profit divided by reported revenue.
83.5%FY2025 · since FY2024: -247.1% → 83.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 83.5% | +330.6 pp |
| FY2024 | -247.1% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ERNAW financial trends
ERNAW RevenueERNAW Net incomeERNAW Net marginERNAW Gross profitERNAW Operating incomeERNAW Operating marginERNAW Operating cash flowERNAW Free cash flowERNAW Capital expendituresERNAW Return on equityERNAW Stock buybacksERNAW Dividends paidERNAW Total assetsERNAW Total liabilitiesERNAW Shareholders’ equityERNAW overview →